Free Shipping on Eligible Prescriptions

Free Shipping on Eligible Prescriptions

Free Shipping on Eligible Prescriptions

Provider Licenses & Credentials

MadeMed is committed to transparency regarding our provider qualifications and licensure. We partner with licensed healthcare professionals who meet the highest standards of care and maintain active licenses in the states where they practice telemedicine.

Dr. Thai Minh Pham, MD


Board-Certified Internal Medicine Physician

Dr. Pham leads MadeMed's medical approach with over 20 years of experience in patient care. A graduate of Brown University with both a medical degree and a bachelor's degree in computer science, Dr. Pham combines clinical expertise with technological innovation to create personalized telehealth solutions.

Active Medical Licenses


- California Medical Board: C 199334
  Valid through: December 31, 2026
Verification Link
- Massachusetts Board of Registration in Medicine: 152422
Verification Link
- Rhode Island Board of Medical Licensure: MD20230
Verification Link
- Vermont Board of Medical Practice: 042.0018113-COMP
Verification Link

Board Certification


- American Board of Internal Medicine (ABIM)
  Certified since: October 1, 1998
  Expiration: April 1, 2025

Education & Training


- Doctor of Medicine, Brown University (1995)
- Bachelor of Science, Brown University
- Residency: Baystate Medical Center (Internal Medicine) - Completed 1998

State Telehealth Requirements


MadeMed complies with all state regulations regarding telehealth practice. In accordance with telehealth laws in California (Cal. Bus. & Prof. Code § 680.5(e)), Massachusetts (Mass. Board of Registration in Medicine Policy 15-05), Rhode Island (R.I. Board of Medical Licensure and Discipline Telemedicine Guidelines), and Vermont (Vt. Board of Medical Practice Policy on Telemedicine), we provide this licensure information publicly to ensure transparency.

For questions about our providers or telehealth services, please contact us.

*Research on brand-name semaglutide shows promising results: non-diabetic adults with obesity lost an average of 15% body weight over 78 weeks when combined with lifestyle changes. Our personalized formulations are different, and results may vary. Talk to your provider about what to expect.

*Research on brand-name semaglutide shows promising results: non-diabetic adults with obesity lost an average of 15% body weight over 78 weeks when combined with lifestyle changes. Our personalized formulations are different, and results may vary. Talk to your provider about what to expect.

*Research on brand-name semaglutide shows promising results: non-diabetic adults with obesity lost an average of 15% body weight over 78 weeks when combined with lifestyle changes. Our personalized formulations are different, and results may vary. Talk to your provider about what to expect.